Although Hodgkin's disease is highly responsive to treatments that cau
se apoptosis, it remains resistant to the physiological mechanisms int
ended to cause cell death. Presumably, the Reed-Sternberg cell defies
endogenous apoptosis, persists, accumulates, and manifests the maligna
nt disorder seen clinically. The Reed-Sternberg cell expresses several
members of the tumor necrosis factor receptor superfamily. This famil
y of receptors is involved in both activation and proliferation of cel
ls, as well as either protection from or initiation of apoptosis in ce
lls expressing these surface proteins. Signals from these receptors af
fect transcription. We reasoned that the activation state and resistan
ce to apoptosis of Reed-Sternberg cells might be attributable to dysre
gulation of genes controling these processes. To determine gene expres
sion by Reed-Sternberg cells, we developed a method of micromanipulati
on, global reverse transcription, and the reverse transcription-polyme
rase chain reaction and applied it to 51 single Reed-Sternberg cells a
nd their variants from six cases of Hodgkin's disease. This report ana
lyzes the gene expression of bcl-xs, bcl-xl, bax-alpha, bax-beta, fadd
, fas, fas ligand (fas L), ice, TNF-alpha, TNF-beta, TNFR1, TNFR2, TRA
F1, TRAF2, TRAF3, clAP2, and tradd at the level of mRNA in the single
Reed-Sternberg cells and their variants. The findings here suggest a m
olecular mechanism for the activated state and in vivo survival occurr
ing in untreated Reed-Sternberg cells of Hodgkin's disease. (C) 1998 b
y The American Society of Hematology.